NCT00192478 - Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524 | Biotech Hunter

Enrollment

217

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

May 31, 2006

Study Completion Date

August 31, 2006

Conditions

Respiratory Syncytial Virus Infections

Interventions

BIOLOGICAL

Medi-524

IM doses of MEDI-524 administered at 3 mg/kg or 15 mg/kg at 30 day intervals

Trial Locations (3)

"Hospital General de Niños Ricardo Gutierrez", Buenos Aires

"Hospital Interzonal General de Agudos Dr. Diego Paroissien", Buenos Aires

Hospital Clinico Pontificia Universidad Catolica de Chile, Santiago